A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

If Monday’s Supreme Court argument is any indication, the days of “independent” agencies acting as a fourth branch of government are numbered. In Trump v. Slaughter, a solid majority of the justices ...

Meta CEO Mark Zuckerberg today announced plans to launch a creative studio that will be led by former Apple UI designer Alan Dye. As we learned earlier today, Dye is leaving his position as Vice ...

When a clinical trial slips from “this month” to “next quarter,” nothing dramatic happens in the Capitol — but in a living room somewhere, a parent reassesses hope. Since the Rare Pediatric Disease ...

The more frequent updates are intended to help integrate new features into the IDE more quickly without compromising their reliability and stability. Since Visual Studio 2017, Microsoft has been ...

Microsoft announced two new Windows 11 recovery features today at the Ignite developer conference, called Cloud Rebuild and Point-in-Time Restore (PITR), that aim to reduce downtime and make it easier ...

Nestled into the southeastern corner of the grounds of Seattle’s Northwest African American Museum is a small chapel, built of light-colored wood. It’s an unexpected sight outside the museum’s vintage ...

The funding was part of a bipartisan measure that Congress approved in response to school shootings, but the Trump administration argued that the grants violated civil rights law. By Michael C. Bender ...

Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...

Sequoia-backed AI design startup Visual Electric said that it is joining search startup Perplexity today. The company noted on its site that the team would be joining a new Agent Experiences group at ...

A new approach to gene therapy for retinitis pigmentosa may help patients with advanced disease regain vision regardless of which genetic mutation is causing the condition. An optogenetic therapy ...